Deprenyl and levodopa and Parkinson's disease progression [4]

Annals of Neurology

Volumn 40, Issue 2, 1996, Pages 267-268

  Fowler, J S ^a   Fazzini, E ^a   Volkow, N D ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBIDOPA PLUS LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PLACEBO; SELEGILINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG HALF LIFE; DRUG WITHDRAWAL; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

EID: 0029788564     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400228     Document Type: Letter

References (0)